Courier Health Secures $50 Million Series B for Biopharma Patient Experience Enhancement
Courier Health, a pioneering technology company focused on managing patient experiences, has announced the successful completion of a $50 million Series B funding round. This investment was led by Oak HC/FT, with additional support from existing investors such as Norwest and Work-Bench. The capital raised will be instrumental in advancing product innovation and reinforcing Courier Health's standing as a premier solution provider dedicated to orchestrating and enhancing patient journeys within the life sciences sector.
Despite significant advancements in clinical science, the engagement and support offered to patients prescribed treatments continue to be inadequate. Challenges arise from fragmented data, varied systems, and a lack of coordination which hampers effective patient management. According to the 2026 State of Patient-Centricity report, a staggering 60 percent of biopharma firms perceive their data as fragmented or ineffective, with fewer than 10 percent demonstrating the data maturity necessary to leverage artificial intelligence effectively.
Courier Health addresses these pressing issues by integrating and connecting relevant patient experience data and systems. Through the application of advanced intelligence, the company is capable of surfacing crucial insights and proactively identifying patients who may be at risk. Moreover, Courier Health seamlessly orchestrates comprehensive experiences throughout the patient journey, enabling a more robust and responsive healthcare framework.
Danny Sigurdson, the founder and CEO of Courier Health, expressed, "Our vision centers on transforming the patient experience in healthcare. We aim to simplify and coordinate the often complex journeys of patients reliant on innovative medications. The partnership with Oak HC/FT not only provides capital but also strategic support essential for accelerating our mission and scaling our Agentic AI capabilities. Enhanced success for our clients translates directly to improved health outcomes for patients, which remains our ultimate goal."
The technology offered by Courier Health comprises extensive data integrations and intelligent workflows powered by context-aware AI. The platform features user-friendly interfaces tailored specifically for market access teams and patient services, in addition to AI agents that can autonomously carry out essential tasks, ensuring consistent automation.
From educational outreach to patient enrollment, prior authorization, and therapy initiation, Courier Health’s system meticulously manages each stage of the patient journey. This holistic management equips biopharma entities with the necessary insights, control, and intelligence critical for ensuring high-quality interactions with healthcare providers, pharmacies, patients, and their families.
Billy Deitch, Partner at Oak HC/FT, remarked, "The life sciences sector has long been in need of a dedicated platform for patient management. While the concept of patient-centricity is often mentioned, it is rarely realized. Courier Health changes this narrative by providing essential infrastructure along with a thoughtful AI strategy, which biopharma is eager to adopt swiftly. We are excited to collaborate with Danny and his team as they establish new standards for patient experiences."
In 2025, Courier Health saw a remarkable increase in its customer base and the therapies supported by its platform, experiencing a growth rate exceeding 400%. This echoed the company's efforts to expand its workforce, which more than doubled in direct response to market demands. The latest funding round will further expedite investments in its innovative technology and skilled team, allowing Courier Health to reach even more customers.
Courier Health, based in New York City, aspires to elevate the patient experience for millions living with chronic conditions or rare diseases. The company is recognized for providing the fastest-growing solution for patient experiences in the life sciences industry, leading to substantial improvements in patient onboarding, adherence to therapies, and overall health outcomes. Courier Health also conducts the exclusive Patient Innovators Summit and publishes the annual State of Patient-Centricity in Biopharma report. The firm is backed by prominent investors, including Oak HC/FT, Norwest, and Work-Bench. For additional information, follow Courier Health on LinkedIn or visit their official website at www.courierhealth.com.
Despite significant advancements in clinical science, the engagement and support offered to patients prescribed treatments continue to be inadequate. Challenges arise from fragmented data, varied systems, and a lack of coordination which hampers effective patient management. According to the 2026 State of Patient-Centricity report, a staggering 60 percent of biopharma firms perceive their data as fragmented or ineffective, with fewer than 10 percent demonstrating the data maturity necessary to leverage artificial intelligence effectively.
Courier Health addresses these pressing issues by integrating and connecting relevant patient experience data and systems. Through the application of advanced intelligence, the company is capable of surfacing crucial insights and proactively identifying patients who may be at risk. Moreover, Courier Health seamlessly orchestrates comprehensive experiences throughout the patient journey, enabling a more robust and responsive healthcare framework.
Danny Sigurdson, the founder and CEO of Courier Health, expressed, "Our vision centers on transforming the patient experience in healthcare. We aim to simplify and coordinate the often complex journeys of patients reliant on innovative medications. The partnership with Oak HC/FT not only provides capital but also strategic support essential for accelerating our mission and scaling our Agentic AI capabilities. Enhanced success for our clients translates directly to improved health outcomes for patients, which remains our ultimate goal."
The technology offered by Courier Health comprises extensive data integrations and intelligent workflows powered by context-aware AI. The platform features user-friendly interfaces tailored specifically for market access teams and patient services, in addition to AI agents that can autonomously carry out essential tasks, ensuring consistent automation.
From educational outreach to patient enrollment, prior authorization, and therapy initiation, Courier Health’s system meticulously manages each stage of the patient journey. This holistic management equips biopharma entities with the necessary insights, control, and intelligence critical for ensuring high-quality interactions with healthcare providers, pharmacies, patients, and their families.
Billy Deitch, Partner at Oak HC/FT, remarked, "The life sciences sector has long been in need of a dedicated platform for patient management. While the concept of patient-centricity is often mentioned, it is rarely realized. Courier Health changes this narrative by providing essential infrastructure along with a thoughtful AI strategy, which biopharma is eager to adopt swiftly. We are excited to collaborate with Danny and his team as they establish new standards for patient experiences."
In 2025, Courier Health saw a remarkable increase in its customer base and the therapies supported by its platform, experiencing a growth rate exceeding 400%. This echoed the company's efforts to expand its workforce, which more than doubled in direct response to market demands. The latest funding round will further expedite investments in its innovative technology and skilled team, allowing Courier Health to reach even more customers.
Courier Health, based in New York City, aspires to elevate the patient experience for millions living with chronic conditions or rare diseases. The company is recognized for providing the fastest-growing solution for patient experiences in the life sciences industry, leading to substantial improvements in patient onboarding, adherence to therapies, and overall health outcomes. Courier Health also conducts the exclusive Patient Innovators Summit and publishes the annual State of Patient-Centricity in Biopharma report. The firm is backed by prominent investors, including Oak HC/FT, Norwest, and Work-Bench. For additional information, follow Courier Health on LinkedIn or visit their official website at www.courierhealth.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.